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Abstract 
 
Background: 
Prostate cancer  is regarded the second cause of death  in men    in developed countries  ,  in 
Sudan it comes in the sixth place following lung , liver ,stomach , colorectal and oesophageal 
cancer. 
Design:  
This study is a cross‐sectional retrospective archival study 
Setting: 
The study was conducted on 376 prostate cases seen in Soba teaching Hospital in the period 
from 2007 to 2009 from these cases 76 were cancer positive. 
Objectives: 
The  cases  studied with  regard  to  age of presentation, pathological  grading using Gleason 
score, association of PIN, perineural invasion, PSA level and the presence of lower UTS. The 
relationship between the Gleason score and age of presentation, PSA level, presence of PIN, 
presence of crystalloid secretions and perineural invasion were studied. 
Methods: 
The  patient’s  files,  reports  and  slides  were  revised.  Data  was  collected  using  tables,  all 
information  about  patient’s  names,  age,  clinical  findings,  their  file  and  identification 
numbers, the diagnosis, Gleason score, presence of PIN, crystalloid secretions and perineural 
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invasion was collected. The data was analyzed using SPSS version 12.and  the  results were 
presented in tables and charts.  
 
 
Results: 
Prostate cancer is more common among patients older than 70 years which constitute about 
60% of the patients and they usually present with high grade disease, in about quarter of the 
cases  we  found  associated  PIN,  PSA  level  was  high  in  some  of  the  cases  and  is  mostly 
associated with high grade cancer. Twenty  five percent of  the cases were associated with 
perineural invasion most of it was of high grade. 
 
Conclusion: 
The results of the study go well with the findings in the world literature , but we had a lot of 
missed data regarding history and prognosis.  
We  recommend  that more  studies are done  specially  in  the area of prognosis and clinical 
progression of the disease. 
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  ّﻠﺺﺴﺘﺨاﻟﻤ
  
 ل 7002 ِﻣْﻦ اﻟﻔﺘﺮِة ﻓﻲ اﻟﺘﻌﻠﻴﻤﻲ ﺳﻮﺑﺎ ﻣﺴﺘﺸﻔﻰ ﻓﻲ ﺑﺮوﺳﺘﺎِت ﺣﺎﻟِﺔ 673 ﻓﻲ ْﺖﻳأﺟﺮدراﺳﺔ وﺻﻔﻴﺔ اﺳﺘﻌﺎدﻳﺔ  اﻟﺪراﺳِﺔ هﺬﻩ
,  درﺟﺔ ﺟﻠﻴﺴﻮن  ,اﻟﻤﺮﻳِﺾﺑُﻌﻤَﺮ ﻳﺘﻌﻠﻖ ﻓﻴﻤﺎ اﻟﺤﺎﻻَت َدرﺳَﻨﺎ إﻳﺠﺎﺑﻴﻪ ﻟﺴﺮﻃﺎن اﻟﺒﺮوﺳﺘﺎت َآﺎﻧْﺖ 67 اﻟﺤﺎﻻِت هﺬﻩ ِﻣْﻦ 9002
  .وﺟﻮد اﻋﺮاض ﻓﻲ اﻟﻘﻨﺎة اﻟﺒﻮﻟﻴﺔو أي إس ﺑﻲﻣﻌﺪل  ،ﻧﺘﺸﺎر اﻟﺨﻼﻳﺎ اﻟﻤﺮﻳﻀﻪ ﺣﻮل اﻻﻋﺼﺎبا NIP       ,وﺟﻮد 
 إﻓﺮازاِتوﺟﻮد ,   NIPوﺟﻮد أي، إس ﺑﻲ ﻣﺴﺘﻮى ،اﻟﻤﺮﻳﺾ  وُﻋﻤﺮ درﺟﺔ ﺟﻠﻴﺴﻮن ﺑﻴﻦ اﻟﻌﻼﻗِﺔ إآِﺘﺸﺎفﺣﺎوﻟﻨﺎ  اﻟﺪراﺳِﺔ ﻓﻲ
  .وﺟﻮد ﺧﻼﻳﺎ ﻣﺮﻳﻀﺔ ﺣﻮل اﻻﻋﺼﺎب  و آﺮﺳﺘﺎﻟﻴﺔ
  
 أﺳﻤﺎِء ﺣﻮل اﻟﻤﻌﻠﻮﻣﺎت ُآّﻞﻓﻲ ﺟﺪاول ﺗﺤﺘﻮي  اﻟﺒﻴﺎﻧﺎتوﻣﻦ ﺛﻢ ﺗﻢ ﺗﺠﻤﻴﻊ .اﻟﻤﺮﺿﻰ وﺷﺮاﺋَﺢ وﺗﻘﺎرﻳَﺮ ﻣﻠﻔﺎتﺗﻤﺖ ﻣﺮاﺟﻌﻪ  
آﺮﺳﺘﺎﻟﻴﺔ و  إﻓﺮازاتوﺟﻮد ,  NIP  وﺟﻮد ،درﺟﺔ ﺟﻠﻴﺴﻮن, اﻟﺘﺸﺨﻴﺺ ,ﺴﺮﻳﺮﻳﺔاﻟﻔﺤﻮﺻﺎت اﻟ ﻧﺘﺎﺋﺞ ،هﻢ رﺎُﻋﻤا اﻟﻤﺮﺿﻰ،
  .ﺟﻮد  ﺧﻼﻳﺎ ﻣﺮﻳﻀﺔ ﺣﻮل اﻻﻋﺼﺎب 
  
 أآﺜﺮ اﻟﺒﺮوﺳﺘﺎِت ﺳﺮﻃﺎِن وﺟﺪ ان .ﻣﺨّﻄﻄﺎِتو ﺟﺪاول ﻓﻲ ُﻗّﺪﻣْﺖ واﻟَﻨﺘﺎِﺋﺞ.  SSPS21ﺑﺮﻧﺎﻣﺞ  ﺳﺘﻌﻤﺎلﺑﺎ ُﺣّﻠﻠْﺖ اﻟﺒﻴﺎﻧﺎت
 اﻟﺬﻳﻦ آﺒﺎر اﻟﺴﻦ اﻟﺒﺎﻟﻐﺔ أﻋﻤﺎرهﻢ أآﺜﺮ ﻣﻦ ﺳﺒﻌﻴﻦ ﺳﻨﺔ و ﻳﻤﺜﻠﻮن ﺣﻮاﻟﻲ ﺳﺘﻴﻦ ﻓﻲ اﻟﻤﺎﺋﺔ ﻣﻦ اﻟﺪراﺳﺔ و ﻤﺮﺿﻰاﻟ ﺑﻴﻦ ﺷﻴﻮﻋًﺎ
 اﻟﺒﻌﺾ ﻓﻲ ﻋﺎﻟَﻲ َآﺎَن أي إس ﺑﻲ ﺘﻮىﻣﺴ ، NIPَوﺟﺪ  اﻟﺤﺎﻻِت ُرْﺑﻊﺣﻮاﻟﻲ  ،ﻳﺘﻢ ﺗﺸﺨﻴﺼﻬﻢ ﻓﻲ ﻣﺮﺣﻠﺔ ﻣﺘﻘﺪﻣﺔ ﻣﻦ اﻟﻤﺮض 
ﺗﺤﺘﻮي ﻋﻠﻰ ﺧﻼﻳﺎ  َآﺎﻧْﺖ ﺧﻤﺴﺔ و ﺷﺮون ﻓﻲ اﻟﻤﺎﺋﺔ ﻣﻦ اﻟﺤﺎﻻت . ﻣﻌﻈﻤﻬﺎ آﺎﻧﺖ ﻣﻦ اﻟﺪرﺟﺔ اﻟﻤﺘﻘﺪﻣﺔ و اﻟﺤﺎﻻِت ِﻣْﻦ
  .اﻟﻤﺘﻘﺪﻣﺔ اﻟﺪرﺟِﺔ ِﻣْﻦ ﻮاَآﺎَﻧ ﻢﻏﻠﺒﻬاﻣﺮﻳﻀﺔ ﺣﻮل اﻻﻋﺼﺎب 
 
 اﻟﺘﺄرﻳﺦ ﺑﺨﺼﻮص اﻟﻤﻔﻘﻮدة ﺒﻴﺎﻧﺎِتاﻟ ِﻣْﻦ اﻟﻜﺜﻴﺮ ِﻋْﻨَﺪﻧﺎ َآﺎَنَﻟﻜﻦﱠ  اﻟﻌﺎﻟِﻢ، ﻓﻲ اﻟﻨﺘﺎﺋِﺞ ﻣﻊ ﺘﻮاﻓُﻖﺗ ﻟﺪراﺳِﺔا ﻧﺘﺎﺋﺞ
ﻣﺎﻳﺘﻌﻠﻖ ﺑﺤﺎﻟﺔ اﻟﻤﺮﺿﻰ ﻋﻠﻰ اﻟﻤﺪى اﻟﻄﻮﻳﻞ وﻣﺮاﺣﻞ  ﻓﻲ ﺧﺎّص ﺑﺸﻜﻞﺟﺮاء اﻟﻤﺰﻳﺪ ﻣﻦ اﻟﺪراﺳﺎت ﺑﺄ َﻧﻮﺻﻲ.واﻟﺘﺸﺨﻴﺺ
 .ﺗﻄﻮر اﻟﻤﺮض
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Introduction: 
Prostate cancer is one of the leading causes of cancer death in men in developed 
countries. In the United States it is the second killing cancer among men headed only 
by lung cancer. Statistical studies estimate that one  out of six men will be diagnosed 
with prostate cancer during his life, and that one out of 35 men will die with prostate 
cancer. Prostate cancer accounts for 10% of cancer related deaths in men. 
The survival rate of patients with prostate cancer is very high reaching 100% for 5 
years,91% for 10 years and76% for 15 years. 
The prognosis in prostate cancer depend on the time of the diagnosis and the degree 
of differentiation along with the extent of the tumor. 
With the new modalities of diagnosis and treatment the survival is far better. 
In Sudan most of the patients are diagnosed late and sometimes at an extensive 
metastatic stage. Data regarding patients survival in Sudan is not available since most 
of them are diagnosed and treated at different places.  
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Literature Review  
The prostate is a pear-shaped glandular organ that weights up to 20 g in the normal 
adult male and that depends for its differentiation and subsequent growth on 
androgenic hormones synthesized in the testis, acting through a poorly understood 
mesenchymal-epithelial interaction. Traditionally, it has been divided into 
anterior,middle,posterior and two  lateral lobes by drawing divergent lines from the 
centrally located urethra. A division that correlates better with the physiologic and 
pathologic features of the organ is to divide it into an inner (periurethral) and outer 
(cortical) zones. The inner zone is the primary site for nodular hyperplasia (and the 
rare carcinomas arising from large ducts), whereas the outer zone is the primary site 
for adenocarcinoma. .The secretary cells, which are located in the luminal side of the 
gland, contribute to a wide variety of products of the seminal fluid. They produce 
prostatic acid phosphatase (PAP) and prostate-specific antigen (PSA) both of which 
can be readily identified immunohistochemically and have been proved to be of great 
diagnostic utility because of their organ-related specificity. PSA is a glycoprotein that 
has been identified as a kallikerin-like protease. Secretory cells also coexpress various 
keratins and vimentin. The keratins do not include high-molecular-weight types such 
as 34 β F12, a fact of diagnostic significance.(1) 
The normal prostatic secretion is a neutral mucosubstance (a feature of some 
diagnostic significance because most adenocarcinomas secrete a mixture of acidic and 
neutral mucins. However, on occasion one encounters scattered columnar mucin-
secreting cells in nonneoplastic prostatic epithelium, particularly in areas of atrophy. 
18 
 
The basal cells form a thin continuous layer that separates the luminal secretary cells 
from the basement membrane. They characteristically contain keratins 34 β E12 and 
312 C8-1 and stain strongly for antikeratin antibody . 
The neuroendocrine cells express chromogranin A and B secretogranin II,and various 
peptide hormones such as somatostatin, calcitonin and bombestin, they coexpress 
PSA,suggesting a common origin with the secretory cells. However, they are negative 
for androgen receptors. 
The large prostatic ducts are lined by transitional epithelium that is continuous and 
indistinguishable from that lining the prostatic urethra. In contrast to bladder 
epithelium, its surface does not display umbrella cells but rather a single layer of 
columnar cells that are immunoreactive for PSA and PAP. On occasion, this 
epithelium undergoes squamous metaplastic changes, these were very common at the 
time that estrogen therapy was widely employed for prostatic carcinoma.(1,2) 
The prostatic stroma is notable because of its large content of smooth muscle fibers, 
whose function is to squeeze out the prostatic secretion when properly stimulated; it 
has been pointed out that the presence of this muscular stroma duplicates the function 
of myoepithelial cells in the other organs, such as breast. Prostatic stroma cells have 
been found to contain androgen receptors. 
Peripheral nerves are evenly distributed in the apex, midgland, and base; they are of 
importance to pathologists because of the high frequency with which the loose 
connective space that surrounds them (formerly thought to represent perineural lymph 
vessels) is involved by adenocarcinomas of this organ. 
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The prostatic lymph vessels drain into the pelvic lymph nodes and from there into 
retroperitoneal chain. 
Diseases affecting prostate gland: 
The prostate gland is subjected to different pathologies including both benign and 
malignant conditions. The gland can be affected by inflammatory conditions both 
acute and chronic ones. It's also affected by benign neoplasms the most common is 
benign prostatic hyperplasia that commonly occur in men older than 40 years and it's 
incidence increase with age reaching 85% with age 80. The gland also is a site of 
leomyoma which arise from the stroma of the gland.   
 
Carcinoma 
General features:  
Carcinoma of the prostate is the most common internal malignancy among men in the 
united states and is responsible for 10% of cancer death in this population. Each year 
in new York state more than 11,000 men are diagnosed with prostatic cancer, and 
more than 2300 die from it. Prostate cancer is the leading cause of new cancer in men 
and is second only to lung cancer as a leading cause of cancer-related deaths in men. 
Rates among black males are one and a half those of white males. The age adjusted 
incidence is on the increase in most countries. Hormonal factors appear to play a role 
in the development of prostatic carcinoma. The disease do not occur in men castrated 
before puberty, and its incidence is low in patients with hyperestrongensim resulting 
from liver cirrhosis. It has been estimated that 5% to 10% of prostatic carcinomas 
have genetic link. If a man's brother or father had prostatic carcinoma his own risk of 
developing the disease is two to three times greater than average. There is no 
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demonstrable correlation with diet, venereal disease, sexual habits, smoking or 
occupational exposure. There is no convincing evidence that patients with nodular 
hyperplasia (or those who have had a transurethral resection for it) are at an increased 
risk for the development of prostatic carcinoma, although the two conditions often 
coexist. 
Almost 75% of the men diagnosed with prostatic cancer are age 65 or older, but the 
tumors can be seen in younger adults and even in the children and adolescents. Their 
frequency increases with age, a fact well substantiated by careful observations at 
autopsy. The frequency with which incidental carcinoma is found at post mortem 
examination varies between 15% and 70% and is directly related to the age of the 
patient and the thoroughness of the sampling.(3) 
Every year about 600 Sudanese men are diagnosed with prostate cancer. And prostate 
cancer is ranked the sixth common cancer in male population preceded by lung 
,stomach,liver,eosphgeal and colorectal cancers.(30,31) 
Clinical features: 
Skillful rectal examination remains a practical and efficient method for the detection 
of prostatic carcinoma; however, pathologic confirmation is always necessary because 
early lesions cannot be distinguished with assurance from foci of nodular hyperplasia, 
granulomatous prostatitis, tuberculosis infarct, or lithiasis. Transrectal 
ultransonography can detect carcinomas  (which appear as hypoechoic lesions) as 
small as 5 mm in diameter; however, it will miss up to 30% of the prostatic tumors 
that are isoechoic and has not proved an efficient tool for screening.(4,32) 
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PSA is secreted by all but the  most undifferentiated prostatic tumors. Gram for gram, 
the average prostatic carcinoma produces ten times or more the amount of PSA 
produced by normal tissue, and this is reflected in the circulatory levels of this 
marker. Serum determination of PSA has all but replaced the time-honored 
determination of PAP. The test has a high sensitivity and specificity to prostatic 
disease, is rapid and inexpensive, and is minimally invasive. Mild serum elevations of 
PSA can be seen with nodular hyperplasia, but levels above 4mg/ml call for serial 
determination, with the performance of a biopsy if they continue to rise. Almost half 
of patients with prostatic carcinoma have levels over 10 mg/ml. Elevations of serum 
PSA also occur in prostatitis, prostatic infarct, and major trauma to the prostate, such 
as needle biopsy or TUR, but these elevations should be transitory and resolve with 
proper treatment. 
The combination of digital rectal examination, transrectal ultransonography, and 
serum PSA represents a powerful diagnostic triad for the detection of early prostatic 
carcinoma. It is not clear whether measurement of the PSA density (PSA level as a 
function of prostatic volume) will provide a more specific test for carcinoma.(5,25,21) 
Pathologic features:  
Prostatic carcinoma can be divided into two major categories;  
(1) adenocarcinoma of peripheral ("secondary") ducts and acini, and  
(2) carcinoma of large ("primary") ducts. 
 This morphologic distinction has traditionally been based on the belief of a different 
site of origin for the two tumors. However (and as in the breast before), this 
histogenetic approach has been challenged by the observation that the two patterns are 
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often seen together, and the alternative proposal has been advanced that it is the site of 
the growth rather than the origin that governs the tumors architecture. The majority of 
the tumors belong to the first category, and most studies dealing with grading, staging, 
prognosis, and therapy of the prostatic carcinoma refer exclusively to them. 
 These two major tumor types may coexist in the same prostate, and that these are rare 
tumors with combined features in the same neoplasm. 
Adenocarcinoma of peripheral ducts and acini: 
 Most prostatic carcinomas arise in the posterior lobe.  More important than this is the 
fact that most prostatic carcinoma arise in the peripheral zone, whether posteriorly, 
laterally, or anteriorly, with sparing of the periurethral region except for the late 
stages of the disease.(5) 
.Grossly, the tumors may be difficult to see but usually can be identified as a gray or 
yellowish, poorly delineated, firm area. Early detection efforts are resulting in the 
identification of increasingly smaller tumors. As a matter of a fact, residual carcinoma 
may be unidentifiable grossly or even microscopically in a radical prostatectomy 
specimen preformed because of a positive biopsy (so-called "vanishing cancer 
phenomenon" or "minimal residual cancer"). The frequency of this finding has 
increased in recent years, probably due to earlier diagnosis and therefore smaller size 
of the original tumors.(5,6) 
Microscopically, prostatic adenocarcinoma exhibit a wide spectrum of appearances, 
ranging from anaplastic tumors to highly differentiated neoplasms that are 
distinguished from the non-neoplastic gland only with great  difficulty. Four major 
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cytoarchitectural patterns occur. medium-sized glands, small glands, diffuse 
individual cell infiltration, and cribriform.  
Carcinomas composed of a medium-sized glands are detected on low-power 
examination by virtue of the closely spaced arrangement of those glands, irregular 
outline, smooth inner surface, and scanty intervening stroma. Tumors made up of 
small glands appear as expansive nodules on low power, the individual glands having 
a regular round configuration and small size. Both of these architectural patterns (but 
particularly the latter) are accompanied by cytologic abnormalities in the form of 
nuclear enlargement, irregularity of contour, hyperchromasia , and most important 
prominent nucleoli ("macronucleoli", defined as a measuring >1 micron in diameter). 
These nucleoli tend to be marginated and often multiple. Mitoses are also of 
significance, but they are rarely found in well-differentiated tumors composed of 
either medium-sized or small glands. The pattern of diffuse cell infiltration resembles 
somewhat that of invasive lobular carcinoma of the breast, whether the cribriform 
pattern has high resemblance to comberable type of breast carcinoma. It has been 
stated that the cribriform pattern represents intraductal carcinoma, as evidence by the 
preservation of the epithelial basal layer.  This pattern is accompanied by clearcut 
invasive carcinoma in the majority of cases; therefore the use of the term "intraductal 
carcinoma" under these circumstances may be misleading. An additional pattern of 
growth that has been  referred to as glomeruloid is characterized by the presence of 
intraluminal ball-like clusters of tumors cells. (7,8) 
Two opposing  morphologic variations of prostatic adenocarcinoma are one in which 
the tumors simulates an atrophic process, and another in which it mimics a benign 
hyperplastic change. The first, described as prostatic adenocarcinoma with atrophic 
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features, is formed by tumors cells with an attenuated cytoplasm, such that the nuclei 
occupy almost the entire cell height. These cells are identifiable as malignant because 
of their infiltrative pattern of growth, nuclear enlargement. The architectural features 
include papillary infoldings, branching, and corpora amylacea. Features identifying 
the lesions as malignant are nuclear enlargement, macronucleoli, mitoses, intraluminal 
crystalloids, and sometimes  the presence of adjacent PIN.(9) 
The patterns just mentioned are often seen in combination. Either synchronously or 
metachronously. also, a patterns of diffuse cell infiltration can be seen after the partial 
removal of a better differentiated neoplasm.  These patterns and their admixture, as 
seen on low-power examination form the basis of Gleason grading scheme . 
Multiple tumors foci have been demonstrated in 75% to 85% of radical prostatectomy 
specimens studies by step-section or whole-mount techniques. They are probably an 
expression of true multicentricity rather than intraglandular tumors spread , as 
supported by their frequent genetic heterogeneity.  Multicentricity is less common in 
the centrally located tumors. 
The presence of prostatic glands within perineural spaces is common in these tumors. 
This finding is a strong indicator of malignancy but is not pathognomonic. It does not 
represent permeation of perineural lymphatic vessels, but rather spread of glandular 
tissue along planes of lesser resistance. Its presence in needle biopsy specimen is a 
good predictor of capsular invasion by tumor.(10) 
The stroma surrounding the neoplastic glands may show a combination of 
hypercellularity and deposition of a basophilic ground substance ("mucinous 
fibroplasias or "collagenous micronodules"). Both intraluminal and stromal 
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calcification may be seen in association with prostatic cancer, but the incidence of the 
latter is much lower than in benign prostate . (11,12) 
Protein crystalloid structures morphologically and immunocytochemically similar to 
Bence Jones crystals are seen in the glandular lumina of 10% to 23% of prostatic 
carcinoma and are particularly common in tumors composed of medium-sixed glands. 
Their presence usually indicates malignancy, but their occasional occurrence in 
benign glands has been documented. When the latter is the case, their presence should 
not be viewed as indicating a significant risk factor for the subsequent development of 
cancer.(12) 
Electron probe x-ray microanalytic studies have shown that they are predominantly 
composed of inorganic sulfur. Exceptionally, these crystalloids are also found in 
metastatic foci. The presence of corpora amylacea in the glandular lumen is not 
necessarily a sign of benignancy; these formations can also be found in association 
with malignant glands, particularly in examples of extensive, moderately 
differentiated tumor. 
The cytoplasm of the carcinoma cells usually has a nondescript finely granular 
appearance, but on occasion it is clear or foamy because of the massive accumulation 
of lipids ("foamy gland carcinoma").  When this feature is widespread, the tumor 
grossly acquires a bright yellow color and a soft consistency, making it difficult to 
detect on rectal palpation even when it is extensive. Its microscopic recognition can 
also be difficult, particularly at metastatic sites. The behavior of these tumors is often 
aggressive despite the deceptively innocuous microscopic features. 
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"Minimal adenocarcinoma” and atypical small acinar proliferation (ASAP) : 
These are tumors in which you can not say wether thy are benign or malignant. For 
the cases in which the recommended threshold is not reached, terms such as "atypical 
gland suspicious of malignancy" and "atypical small acinar proliferation (ASAP) 
suspicious of malignancy" have been proposed. Also, these terms are mired in 
controversy, the main objection being that they do not represent morphologic entities. 
Semantics aside, the fact remains that certain number of prostatic biopsies (about 4% 
to 6%) cannot be confidently placed into a benign or malignant category (with or 
without 34BE immunostainings), and it seems to us wholly appropriate to express this 
uncertainly in the pathology report, whether using the ASAP acronym or with a 
descriptive ''canned'' text, as frustrating as this may be for the urologist and the 
patient. One thing is certain: a patient with such a diagnosis warrants a second 
biopsy(13) 
Carcinoma of large ("primary") ducts : 
The other major (but numerically less significant) category of prostatic carcinoma 
originates from the large (primary) ducts that are normally found in a periurethral 
location. Cystoscopic examination often shows a polypoid villous or an infiltrative 
urethral component. Microscopically, the following types have been recognized .(14)  
1. Large (prostatic) duct adenocarcinoma. This tumor is characterized by malignant 
changes in large dilated ducts, often shows by papillary foci and occasionally by a 
clear cell (mesonephroid) component. Sometimes the tumor is accompanied by 
pagetoid spread in the prostatic urethra. Some cases of this entity have been 
reported in the past as Paget's disease and Bowen's disease . Positivity for PSA 
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and PAP is the rule. The tumor tends to have a more advanced stage at 
presentation and a higher short-term survival rate than peripheral duct-acinar 
carcinomas. (15) 
 
Endometrial-type (endometrioid) adencarcinoma was originally described as 
arising  from the prostatic utricle (a mullerian remnant thought to represent the 
male homolog of the female uterus and vagina) but is currently regarded as a 
variant of large duct prostatic adencarcinoma. Microscopically, glands and 
papillae are seen, lined by tall,pseudostratified columnar epithelium. 
Microscopic studies, immunocytochmical determinations (positivity for PAP 
and PSA), and the response to orchiectomy indicate that his tumor is truly of 
prostatic origin.(15,18) 
2. Primary transitional cell (urothelial) carcinoma of the prostate. The existence of 
this tumor type is explained by the fact that the outer portion of the prostatic 
(periurethral) ducts emptying into the urethra are lined by transitional epithelium. 
This variant comprises less than 2% of all prostatic carcinomas. The microscopic 
appearance of this neoplasm is identical to that of the homonymous bladder 
tumor. The diagnosis can be made in prostatic needle biopsies and in TUR 
specimens. Before a diagnosis of primary transitional cell carcinoma of prostate  
is made, the possibility of prostatic extension from a bladder or urethral carcinoma 
should be excluded.(16,17,18) 
3. Mixed adencarcinoma-transitional cell carcinoma, exhibiting a combination of 
types 1 and 2. Sometimes tumors having any of the appearances listed previously 
are seen associated with an ordinary prostatic adencarcinoma or with an 
independent transitional cell tumor of the bladder. The mode of presentation, 
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initial stage, and response to hormone therapy for the carcinoma arising from 
large ducts(with the possible exception of pure transitional cell carcinoma) are 
similar to those of the conventional prostatic adencarcinoma. Atypical hyperplasia 
and carcinoma in situ of periurethral glands, presumably representing the 
precursors of large duct carcinomas, have been observed.(19,20) 
4. Other microscopic types include: 
1- Carcinoma with neuroendocrine features . 
2- Mucinous secreting adencarcinoma, they secrete large amounts of intracellular and 
extracellular mucin. 
3- Signet ring carcinoma, it's highly malignant neoplasm which may grow in 
solid,acinar or Indian file pattern. 
4- Adenosquamus carcinoma, may arise denovo or after radiation. 
5- Squamus cell carcinoma, is a rare neoplasm. 
6- Adenoid basal cell tumor, resembles adenoid cystic carcinoma of the salivary 
gland. 
7- Basaloid carcinoma. 
8- Lymphoepithelioma like carcinoma. 
9- Tubulocystic clear cell adenocarcinoma, resembling mullerian-type adencarcinoma 
of the female genital tract. 
10- Sarcomatoid carcinoma. 
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Intraepithelial proliferative lesions: 
Prostatic intraepithelial neoplasia (PIN) is the currently preferred term for a process 
involving prostatic ducts and acini,which has also been described as intraductal or 
ductal-acinar dysplasia, it is often multicentric.  (28,29) 
PIN is divided into three grades, depending on the severity of the following 
alterations:  cell crowding and stratification; nuclear enlargement,pleomorphsim,and 
chromatin pattern; and nuclear appearance. These three grades are currently grouped 
into two categories: low-grade PIN (I,II) and high-grade PIN (III) (9) 
Several studies have shown a statistical association between high-grade PIN and 
prostatic carcinoma, in the sense that PIN has been found in 59% to 100% of step-
sectioned radical prostatectomy specimens. It has also been shown that in prostates 
containing both PIN and adenocarcinoma, there is a good degree of concordance in 
the DNA ploidy pattern of both lesions. 
These findings have led to the suggestion that PIN may have a high predictive value 
as a marker for carcinoma and to the recommendation to follow closely patients in 
whom PIN is identified in a prostatic biopsy. 
Microscopic differential diagnosis :  
1- Radiation changes. 
2- Basal cell hyperplasia. 
3-Transitional cell hyperplasia. 
4- Squamus metaplasia. 
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5- Cribriform hyperplasia. 
6- Sclerosing adenosis. 
7- Florid hyperplasia of mesonephric remnants. 
 
Grading and staging:  
Several grading systems have been described, of which the Gleason system is the best 
known. According to the Gleason system,prostate cancers are stratified into five 
grades on the basis of glandular patterns and degree of differentiation as seen under 
low magnification. 
Gleason system 
1- Single,seperate,uniform glands in closely packed masses with a definite, usually 
rounded, edge limiting the area of tumor. 
2- Single,seperate,slightly less uniform glands, loosely packed (separated by small  
amounts of stroma), with less sharp edge. 
3a- Single-separate, much more variable glands, may be closely packed but usually 
irregularly seperated;ragged,poorly defined edge. 
3b- Like 3a, but very small glands or tiny cell clusters. 
3c- Sharply and smoothly circumscribed rounded masses of papillary or loose 
cribriform tumor ("papillary intraductal tumor"). 
4a- Raggedly outlined raggedly infiltrating, fused glandular tumor. 
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4b- Like 4a,with large pale cells ("hypernephoid") 
5a- Sharply circumscribed, rounded masses of almost solid cribriform tumor,usually 
with central necrosis ("comedocarcinoma"). 
5b- Ragged masses of anaplastic carcinoma with only enough gland formation or 
vacuoles to identify it as adencarcinoma. 
The Gleason score is the sum of the grade of the most dominant pattern with the lest 
dominant one and start from 2 to 10.and accordingly divided into 3 grades 2-4 well 
differentiated ,5-7 moderately differentiated and 8-10 poorly differentiated cancers.  
Staging of prostatic cancer is also important in the selection of the appropriate form of 
therapy. The most common staging system is the TNM system. stage T1 refers to 
cancer found incidentally either on trans-urethral resection done for BPH symptoms 
(T1 and T1b depending on the extent and grade) or on needle biopsy, typically 
preformed for elevated serum PSA levels (stage T1c). stage T2 is organ confined 
cancer. 
Stage T3a and T3b tumors show extraprostatic extension, with and without seminal 
vesicle invasion, respectively. Stage T4 reflects direct invasion of contiguous organs. 
Any spread of tumor to the lymph nodes ,regardless of extent, is eventually associated 
with a fatal outcome, such that the staging system merely records the presence or 
absence of this finding (N0/N1) 
Histochemical and immunohistochemical features: 
Prostatic adenocarcinomas produce acid mucins which stain positive for Alcian blue 
or colloidal iron, they are also positive for PAP and PSA.(21,22) 
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They also produce the membrane bound glycoprotein prostate specific membrane 
antigen and it's expressed with increased frequency with high grade cancer. 
Prostatic carcinoma cells are often immunoreactive for androgen and progestron 
receptors but much less than estrogen and this is related to the Gleason score.(23,26) 
Her-2-neu is over expressed in androgen -independent prostatic carcinoma. 
Prostatic carcinoma cells are reactive for low molecular weight keratin, they also stain 
positive for leu7, EMA, carcinoembryonic antigen, B72.3, cathepsin D and PTH-
related protein.(24,25) 
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Research Methodology: 
Type of study: 
Retrospective archival study. 
Objectives: 
Major: to study prostatic cancer in Sudanese patients seen in Soba Teaching Hospital 
in the period from January 2007 to December 2009 . 
Minor: 
1- To study the most common variants of prostate cancer in Sudanese patients. 
2- To study the finding in histological sections. 
3- To stratify the patients according to the degree of differentiation. 
4- To identify the presence or absence of perinural invasion as a prognostic 
feature. 
5- To specify the relation between Gleason score and perinural invasion, 
presence of crystalloid secretions,PSA level and PIN. 
 
Research area: 
Soba teaching hospital. 
Research population: 
All patients who underwent prostate biopsies either whole, transurethral or true cut 
biopsies and their specimens were sent to the lab. 
Inclusion criteria: 
Patient presented to Soba teaching hospital who are having clinical reports and 
available slides or blocks. 
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Exclusion criteria: 
Patients with difficient data or missed slides or blocks . 
Materials: 
1-H&E stained sections prepared from formalin embedded blocks  
2- Patients repots and files. 
3-Light microscopy of the slides. 
 
 
Data collection: 
Data was collected by filling tables that contain informations about the 
following. 
1-Lab no. 
2-Patient age. 
3-Histological diagnosis. 
4-Gleason score. 
5-Presence of perineural invasion. 
6-The presence of PIN. 
7-The presence of crystalloid secretions. 
8-The PSA level. 
9-The presence of lower urinary tract symptoms. 
10-The PR findings. 
11- The specimen type. 
Data analysis using SPSS program. 
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Results: 
Table 1: Age distribution among the study group  
 
 
 
 
 
 
Age (Yrs) Frequency Percentage 
(%) 
50-59 5 6.6 
60-69 26 34.2 
70-79 42 55.3 
> 80 3 3.9 
Total 76 100.0 
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Table 2: Gleason score distribution among the study group 
Gleason score Frequency Percentage 
(%) 
2-4 5 6.6 
5-7 21 27.6 
8-10 44 57.9 
BPH with PIN 6 7.9 
Total 76 100.0 
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Table 3: Perineural invasion distribution among the study group 
Perineural 
invasion 
Frequency Percentage 
(%) 
Yes 19 25.0 
No 55 72.4 
Small biopsy, 
unable to detect 
2 2.6 
Total 76 100.0 
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Table 4: Associated PIN distribution among the study group 
Associated PIN Frequency Percentage 
(%) 
Yes 8 10.5 
No 68 89.5 
Total 76 100.0 
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Table 5: Presence of crystalloid secretions distribution among the 
study group 
Crystalloid 
secretions 
Frequency Percentage 
(%) 
Yes 17 22.4 
No 59 77.6 
Total 76 100.0 
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Table 6: PSA level distribution among the study group 
PSA level Frequency Percentage 
(%) 
5 1 1.3 
8 5 6.6 
9 2 2.6 
10 3 3.9 
12 3 3.9 
14 2 2.6 
16 1 1.3 
Missing 
information 
59 77.6 
Total 76 100.0 
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Table 7: Lower urinary tract symptoms distribution among the study 
group 
Lower urinary 
tract symptoms
Frequency Percentage 
(%) 
Yes 43 56.6 
No 33 43.4 
Total 76 100.0 
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Table 8: PR findings distribution among the study group 
PR findings Frequency Percentage 
(%) 
Firm 17 22.4 
Hard 14 18.4 
Not mentioned 45 59.2 
Total 76 100.0 
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Figure (6a)  High grade prostatic adenocarcinoma Gleason grade (4+5) in a 60 years old 
patient & E Stain × 10 
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Figure (6b) high grade prostatic adenocarcinoma with perineural invasion .H&E Stain ×40 
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Figure(7) poorly differentiated prostatic adenocarcinoma Gleason grade (5+5) H&E stain × 10 
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Figure (8) low grade prostatic adenocarcinoma Gleason grade (1+4). H&E  ×10 
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Figure (9)Prostatic adenocarcinoma Gleason grade (5+2) H&E Stain × 20 
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Figure (10) High grade prostatic adenocarcinoma Gleason grade (5+4) with perineural 
invasion H&E stain × 20 
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Figure (11a) Low grade prostatic adenocarcinoma Gleason grade (2+3) showing intraluminal 
secretions H&E Stain × 20 
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Figure (11b) PAS stain for intraluminal secretions in al low grade prostatic adenocarcinoma 
Gleason grade (2+3) × 20 
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This study was conducted on cases seen in Soba University Teaching hospital in the 
period from 2007 to 2009. Of the 412 prostate cases presented to the histopathology 
department 36 cases were excluded because of missed slides or blokes. Of the 
remaining 376 cases, 76 cases where found to be prostate cancer. 
The cases were studied in relation to age, Gleason score, perineural invasion, presence 
of crystalloid secretions, PSA level, the presence of lower urinary tract symptoms and 
the PR examination findings. 
Table 1 shows the age distribution of the study group which was divided into four 
categories, 5 cases were found in the age 50-59 which represent 6.6%, 26 cases 
belong to age group of 60-69 which represent 34.2%, 42 cases were in those aging 70-
79 and represent 55.3%, and 3 cases were found in patients aging more than 80 years 
and this represent 3.9% of the cases. 
As we can see in table  2 of the 76 studied cases 5 were of low grade which account 
for 6.6%, 21 cases proved to be of intermediate grade and represent 27.6%, and 44 
cases diagnosed as high grade forming 57.9% of the cases. 
Of the studied cases 19 were associated with perineural invasion forming 25.7% of 
the cases as we can see in table 3. Of the 76 cases studied 8 were found to have 
accompanying PIN which represents 10.5% of the cases of these 5 cases have high 
grade PIN and 3 have Low grade PIN as presented in table 4. 
Table 5 shows that 17 cases of this collection show crystalloid secretions within the 
glands giving  22.4% of the cases.  
The information about the PSA level was incomplete because most of the patients 
files do not contain such information but in 17 cases the PSA level where above 4 
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micro gram/ml and of these 9 cases have a PSA level above 10micro gram/ml as 
shown in table 6. 
Of the total 76 cases 43 have experienced lower urinary tract symptoms representing 
56.6% in the remaining 33 cases the information was missing in the files as presented 
in table 7. 
Table 8 presenting the PR findings of the study group which were mentioned only in 
the files of 31 cases, in the remaining the information was missed. Of these 17 cases 
have firm prostates in PR examinations and 14 have hard prostates. 
5 cases of benign nodular hyperplasia have associated PIN 2 of them were high grad 
PIN and 3 of them are of low grade. One case of high grade prostate cancer was 
associated with high grade PIN, and 2 cases of low grade prostatic cancer were 
associated with high grade PIN. the Chi-square of this test was .051 which is 
significant.(see figure 1) 
 Of the five cases representing low grade cancer three cases were  in the age group of 
60-69 years one case in each age group of 70-79 years and more than 80 years while 
no cases found in the age group of 50-59 years. The 21 intermediate grade cases 
distributed as follows, three in the age group of 50-59years, six cases  in the patients 
of 60-69years, twelve cases found in the age group of 70-79 years and no cases  in the 
older age group. In the 44 cases that were of high grade one case found in the age 
group 50-59 years, 14 cases belong to 60-69 years old patients, 28 cases among age 
group of 70-79 years and one case in the older age, the chi-square test for this 
correlation was .05 which is considered statistically significant.(see figure 2).  
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Most of the elevations in the PSA level were associated with high grade prostatic 
carcinoma, followed by intermediate grade and low grade respectively and the chi-
square test for this correlation was .051 which is statically significant.(see figure 3). 
Of the 19 cases associated with perineural invasion 14 cases were of high grade 
prostatic cancer, 5 cases  of intermediate grade and no cases of low grade cancer was 
associated with perineural invasion the chi-square test for this correlation was .291 
which is  statistically insignificant.(see figure 4). 
Of the 17 cases having crystalloid secretions in the glands; 11 cases were of 
intermediate grade, 4 of high grade and 2 of low grade cancer. And the crystalloid 
secretions were associated mainly with cases containing Gleason grade 2 cancer. The 
chi-square test for this correlation was statistically significant.(see figure 5) 
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Conclusion and recommendations: 
 
From the results we had we concluded that prostatic cancer in Sudan is a disease of 
old age which goes with the general trend in the world , but it differs in the fact that 
more than 50% of the cases we found to be of high grade where as in the world most 
of the cases are well differentiated. This difference may be a true difference in the 
type of cancer and might be resulting from the fact that Sudanese patient seek clinical 
advice late in the disease.(33) 
Also in our study most of the affected patients were above 70 years of age and these 
have more poorly differentiated tumors, which goes well with the world literature.(34) 
In our study only 10% of the cases contained associated PIN lesion where as the 
literature mentioned  80% the cases  contain a precursor lesion , this difference might 
result because  of the cases we studied were true cut biopsy and the amount of  the 
tissue screened was small.(26,29) 
The information about PSA level were incomplete but most of the elevations were 
associated with high grade cancer which is the case in other countries.(22) 
The presence of crystalloid secretions in the glands which is mostly associated with 
low grade cancer detected in 22% of the cases which is slightly lower than the 27% 
mentioned in the literature.(11,12) 
While conducting this study we were trying to find out some information about the 
risk factors and the prognosis in Sudanese patients but the clinical informations were 
missing although the urology department at Soba teaching hospital has designed a 
good card which cover all the aspects of clinical presentation, lab results ,radiology 
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findings and follow up aspects but the cards were not filled properly in most of the 
cases . 
The study of prostate cancer in Sudan needs more effort in all aspects specially in the 
fields of risk factors and the response to treatment. Also we need to start a good 
screening program because most of the cases present with high grade cancer. 
In this study we did not include the clinical extent of the disease due to incomplete 
data , so further studies regarding the extent of the disease at presentation are needed 
with use of radiological and intra operative data. 
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